Investigation of the potential role of membrane CD38 in protection against cell death induced by HIV-1

Journal of Biological Regulators and Homeostatic Agents

Volumn 10, Issue 1, 1996, Pages 13-18

  Savarino, A ^a   Pugliese, A ^a   Martini, C ^b   Pich, P G ^b   Pescarmona, G P ^a   Malavasi, F ^c  

^a UNIVERSITY OF TURIN   (Italy)

^b AMEDEO DI SAVOIA HOSPITAL   (Italy)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

CD38; CD4+ T cell lines; Cell death; HIV 1; Nicotinamide

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSE; ANTIGEN P24; CD38 ANTIGEN; CD4 ANTIGEN; MEMBRANE ANTIGEN; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE NUCLEOSIDASE;

ANTIGEN EXPRESSION; ARTICLE; CELL DEATH; CELL LINE; CELL PROTECTION; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RESISTANCE; T LYMPHOCYTE;

EID: 0030462192     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Malavasi F, Funaro A, Roggero S, Horenstein A, Calosso L, Mehta K. Human CD38: a glycoprotein in search of a function. Immunol Today 1994; 3: 95.
2. Mehta K, Shahid U, Malavasi E Human CD38, a cell surface molecule with different functions. FASEB J 1996 (in press).
3. + lymphocytes. J Immunol 1994; 22: 952-9.
4. Deaglio S, Dianzani U, Horenstein AL, et al. A human CD38 ligand: a 120 kDa protein predominantly expressed by endothelial cells. J Immunol 1996; 156: 727-34.
5. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 1989; 234: 1562-9.
6. Prince HE, Jensen ER. Three-color cytofluorimetric analysis of CD8 cell subsets in HIV-1 infection. J Acq Immun Def Synd 1991; 4: 1227-32.
7. Funaro A, Horenstein A, Malavasi F. Human CD38: a versatile leucocyte molecule with emerging clinical prospectives. Fund Clin Immunol 1995; 3: 101-11.
8. Lathey JL, Kanangat S, Rouse BT, Agosti JM, Spector SA. Dysregulation of cytochine expression in monocytes from HIV-positive individuals. J Leuc Biol 1994; 56: 347-52.
9. + glucohydrolase, ADP-ribosyl cyclase and cyclic ADP-ribose hydrolase activities in the outer surface of human erythrocytes. Biochem Biophys Res Commun 1993; 196: 1459-65.
10. Murray MF, Nghiem M, Srinivasan A. HIV infection decreases intracellular nicotinamide adenine dinucleotide (NAD). Biochem Biophys Res Comm 1995; 212: 126-31.
11. Pauwels R, De Clerq E, Desmyter J et al. Sensitive and rapid assay on MT-4 cells for detection of antiviral compounds against the AIDS virus. J Virol Meth 1987; 16: 171-85.
12. Pugliese A, Comito G, Savarino A, Cantamessa C, Tone D. Expression of fibronectin and its receptor in some tumour cell lines and in HIV-1-infected cells. Cell Biochem Funct 1996; 14: 105-10.
13. Malavasi F, Calligaris-Cappio F, Milanese C, Dellabona P, Richiardi P, Carbonara A. Characterization of a murine monoclonal antibody specific for human early lymphoheraopoietic cells. Hum Immunol 1984; 9: 9-20.
14. Murray MF, Srinivasan A. Nicotinamide inhibits HIV-1 in both acute and chronic in vitro infection. Biochem Biophys Res Commun 1995; 210: 954-9.
15. Howard M, Grimaldi JC, Bazan JF, et al. Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38. Science 1993; 262: 1056-9.
16. Fauci AS. The human immunodeficiency virus. Infectivity and mechanism of pathogenesis. Science 1988; 239: 617.
17. Furlini G, Re MC, La Placa M. Increase poly(ADP-ribose) polymerase activity in cells infected by human immunodeficiency virus type 1. Microbiologica 1991; 14: 141-8.
18. Sethi JK, Empson RM, Galione A. Nicotinamide inhibits ADP-ribose-mediated calcium signaling in sea urchin eggs. Biochem J 1996; 319: (in press).
19. 2+ levels. New Microbiol 1994; 17: 85-92.
20. Dianzani U, Bragardo M, Buonfiglio D, et al. Modulation of CD4 lateral interaction with lymphocyte surface molecule induced by HIV-1 gp120. Eur J Immunol 1995; 25: 1306-11.